Non-alcoholic fatty liver disease (NAFLD) represents the most common liver disease worldwide affecting approximatively 20–30% ...

Inclusion of pathogenic mechanisms in treatment design will allow future therapies to target-specific pathways involved in NAFLD pathogenesis. This review will focus on the current status of NAFLD ...

Discover the causes behind fatty liver disease, a condition affecting 25% of adults worldwide, and learn simple lifestyle ...

According to the guidelines, diet and exercise are the main aspect in the treatment of non-alcoholic fatty liver disease, now known as metabolic-dysfunction-associated fatty liver disease (MAFLD).

It broadened our traditional understanding of how triglycerides and cholesterol are regulated during the progression of NAFLD." Currently, treatment options for NAFLD are limited; the main ...

Doctors and experts gathered late last year in Bonifacio Global City to raise awareness on a “silent epidemic” that is ...

Here’s how to prevent it.(Image by Freepik) On the growing global burden of NAFLD and current treatment approaches Dr Gyanranjan Rout, Consultant-Medical Gastroenterologist at Manipal Hospital ...

Further worrisome are recent data showing a high prevalence of NAFLD in obese Indian children.” Today, an increasing number of children are affected by Non-Alcoholic Fatty Liver Disease.

Resmetirom significantly reduced liver stiffness in patients with compensated MASH cirrhosis, with a 6.7 kPa decrease over 2 years. The reduction in liver stiffness may lower the risk of liver ...